Screening for celiac disease: could early diagnosis improve lives?
NCT ID NCT07366151
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 250 adults in Finland who were previously screened for celiac disease to see how early diagnosis affects their long-term health, diet habits, and quality of life. Researchers will track symptoms, gluten-free diet adherence, and overall well-being. The goal is to understand whether active screening leads to better outcomes and to learn more about the natural course of untreated celiac disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could show that screening for celiac disease improves long-term health and quality of life, and help clarify how untreated 'potential' celiac disease progresses.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't test a new therapy. Results may take years and might not lead to changes in screening guidelines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tampere University, Faculty of Medicine and Health Technology
Tampere, 33520, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug outperform standard care for a rare liver disease in teens?
- Timing of stoma reversal could cut hospital stays
- Could a lesson in Gluten-Free eating boost Kids' health?
- Wheat sensitivity linked to fatty liver? a new study investigates
- Gluten: friend or foe for elite athletes?
- Blood test plus symptom check may spare thousands from celiac biopsy